Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity

Subcutaneous Fat Disorder Clinical Trial

Official title: A Randomized, Double-Blind, Bilateral Comparison Study of the Safety and Efficacy of 10XB-101 in Adult Subjects With Bilateral Flank Adiposity

Status Active, not recruiting

Clinical Trial Summary

The goal of this clinical trial is to test the safety and effectiveness of an injection study drug in decreasing bilateral flank adiposity.

The main question it aims to answer is:

•How safe and effective is the injection study drug in removing bilateral flank adiposity compared to a placebo?

Participants will be:

• Be given injections every month for 5 months over the right and left flanks.

• Be asked to be seen in the clinic for 13 visits and 3 phone call visits during a duration of 1 year.

Clinical Trial Description

Fifteen subjects with bilateral flank adiposity will be enrolled across 1-3 sites in the USA. ;

Related Conditions & MeSH terms

• Lipid Metabolism Disorders
• Subcutaneous Fat Disorder

• NCT number: NCT05760248
• Study type: Interventional
• Source: 10xBio, LLC
• Status: Active, not recruiting
• Phase: Phase 2
• Start date: May 4, 2023
• Completion date: December 26, 2024